Julian Kissmann

Broadly Protective Shigella Vaccine Based on Type III Secretion Apparatus Proteins

Francisco J. Martinez-Becerra, Julian Kissmann, Jovita Diaz-McNair et al. · Infection and Immunity · 2011 · 147 citations · Full text

Shigella Spp, Pathogen Detection, Microbial Pathogens +22

Formulation Design and High-Throughput Excipient Selection Based on Structural Integrity and Conformational Stability of Dilute and Highly Concentrated IgG1 Monoclonal Antibody Solutions

Akhilesh Bhambhani, Julian Kissmann, Sangeeta B. Joshi et al. · Journal of Pharmaceutical Sciences · 2011 · 65 citations

Structural Integrity, Engineering, Peptide Engineering +11

Stabilization of measles virus for vaccine formulation

Julian Kissmann, Salvador F. Ausar, Angela R. Rudolph et al. · Human Vaccines · 2008 · 63 citations

Physical Stabilization of Norwalk Virus‐Like Particles**The views, opinions and/or findings contained in this report are those of the author(s) and should not be construed as an official Department of the Army position, policy or decision unless so designated by other documentation.

Julian Kissmann, Salvador F. Ausar, Thomas R. Foubert et al. · Journal of Pharmaceutical Sciences · 2008 · 54 citations

Virology, Official Department, Medicine +2

H1N1 Influenza Virus-Like Particles: Physical Degradation Pathways and Identification of Stabilizers

Julian Kissmann, Sangeeta B. Joshi, Joel R. Haynes et al. · Journal of Pharmaceutical Sciences · 2010 · 28 citations

Virus Structure, Protein Folding, Molecular Biology +5